Lannett: Building Success One Step At A Time [Seeking Alpha]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Seeking Alpha
Lannett: Building Success One Step At A Time Summary All businesses face external threats that typically exist within the socio-legal-political-competitive environments in which they operate. Lannett is no exception. Many of the threats Lannett faces are common to pharma businesses, particularly when focused on the highly competitive generic drug business. Lannett acknowledged and well documented its commonly understood threats in their SEC filings, including their 2019 annual report and Q1 2020 report. Of note are specific threats mentioned as being “existential” which some believe question of the viability of Lannett as a business. These threats are the basis for this article. It has long been said, and as history proves, bad things happen to good people. And it follows that bad things happen to good companies. Good companies fail. Evidence? How about a quick comparison of the Fortune 25 for the year 2000 to that for the year 2019 finds only 8 companies from the 2000 list still exi
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Food Allergy Treatment Drug Market to Register Immense Growth by 2032, Assesses DelveInsight | Key Companies - Vedanta Biosciences, Novartis, Alladapt Immunotherapeutics, Regeneron Pharmaceuticals, Genentech, Parexel [Yahoo! Finance]Yahoo! Finance
- Global Macular Degeneration Treatment Market to Soar to USD 23.29 Billion by 2029, Reveals Latest Industry Analysis [Yahoo! Finance]Yahoo! Finance
- Novartis (NVS) Declines More Than Market: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- 1 Magnificent Dividend Stock to Buy and Hold [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 1/31/24 - Miss
NVS
Sec Filings
- 2/15/24 - Form S-8
- 2/2/24 - Form SC
- 1/31/24 - Form 6-K
- NVS's page on the SEC website